Home » Topics » Regulatory » Patents

Patents
RSS

Idorsia Pharmaceuticals patents LGALS3 inhibitors

April 29, 2022

Merck & Co. presents DGAT-2 inhibitors

April 29, 2022

Dana-Farber Cancer Institute discloses new HER2 inhibitors

April 29, 2022

Vertex Pharmaceuticals patents CFTR potentiators

April 29, 2022

University of California discloses new PRMT8 inhibitors

April 29, 2022

Medy-Tox patents new BTK inhibitors

April 28, 2022

University of Texas System identifies CBP and/or p300 inhibitors

April 28, 2022

Humanwell Healthcare presents new P2X3 receptor antagonists

April 28, 2022

New YAP1/TEAD interaction inhibitors disclosed by SpringWorks Therapeutics and collaborators

April 28, 2022

Chinese researchers divulge new compounds for cancer

April 28, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...